Hellerup, Denmark

Ascendis Pharma Bone Diseases A/s


USPTO Granted Patents = 10


Trademarks = 3

Forward Citations = 28

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Kennett Sprogøe (10 out of 28 patents)

silverMedal Felix Cleemann (8 out of 23 patents)

bronzeMedal Thomas Wegge (8 out of 38 patents)

4 Guillaume Maitro (8 out of 13 patents)

5 Joachim Zettler (8 out of 13 patents)

6 Mathias Krusch (8 out of 10 patents)

7 Lars Holten-Andersen (5 out of 6 patents)

8 David Brian Karpf (5 out of 16 patents)

9 Julia Baron (1 out of 2 patents)

10 Michael Duelund Sørensen (1 out of 1 patent)

11 Eric Hoffmann (1 out of 1 patent)

12 Anja R H Skands (1 out of 2 patents)

13 Lars Holten-andersen (0 patent)

14 Kennett SprogØe (0 patent)

15 Claus Strange (0 patent)


10 patents:

Ascendis Pharma is a biopharmaceutical company focused on developing innovative therapies for rare bone diseases. Their pipeline includes potential treatments for conditions such as hypoparathyroidism and osteogenesis imperfecta. By leveraging their TransCon technology platform, Ascendis aims to address the unmet needs of patients with these debilitating disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

10 Patents

#4 in Hellerup

#261 in Denmark

#54,204 in the World

...
Hellerup, Denmark
Forward Citations = 28

15 inventors:

Please report any incorrect information to support@idiyas.com
Loading…